论文部分内容阅读
There is increasing acknowledgement of the existence of patient subgroups within clinical research.As a consequence,many clinical trials look to perform subgroup analysis to assess whether a treatment is effective for those patients with,and those without,a specific biomarker.However,it is not always possible to measure a biomarker with perfect diagnostic accuracy meaning the observed subgroups will be subject to misclassification error.